Cargando…
Matrix Metalloproteinase 2 as a Pharmacological Target in Heart Failure
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in cardiac output and an increase in intracardiac pressure at rest or upon exertion. The pathophysiology of HF is heterogeneous and results from an initial harmful event in the heart that promotes neurohormonal ch...
Autores principales: | Gonçalves, Pricila Rodrigues, Nascimento, Lisandra Duarte, Gerlach, Raquel Fernanda, Rodrigues, Keuri Eleutério, Prado, Alejandro Ferraz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331741/ https://www.ncbi.nlm.nih.gov/pubmed/35893744 http://dx.doi.org/10.3390/ph15080920 |
Ejemplares similares
-
BmooMPα-I, a Metalloproteinase Isolated from Bothrops moojeni Venom, Reduces Blood Pressure, Reverses Left Ventricular Remodeling and Improves Cardiac Electrical Conduction in Rats with Renovascular Hypertension
por: Estrada, Jorge Eduardo Chang, et al.
Publicado: (2022) -
Doxycycline Decreases Atherosclerotic Lesions in the Aorta of ApoE(-⁄-) and Ovariectomized Mice with Correlation to Reduced MMP-2 Activity
por: Rodrigues, Keuri E., et al.
Publicado: (2022) -
Matrix Metalloproteinases and Arterial Hypertension: Role of Oxidative Stress and Nitric Oxide in Vascular Functional and Structural Alterations
por: Prado, Alejandro F., et al.
Publicado: (2021) -
The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
por: Das, Nabangshu, et al.
Publicado: (2020) -
Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute
Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)